Bart Frederick
Impact in
- Immunology top 5%
- Psoriasis: Treatment and Pathogenesis
- Immunodeficiency and Autoimmune Disorders
- Biosimilars and Bioanalytical Methods
- Dermatology top 5%
- Dermatology and Skin Diseases
Papers in
-
- Psoriasis: Treatment and Pathogenesis 4
- Biosimilars and Bioanalytical Methods 3
- Complement system in diseases 1
-
- Erythropoietin and Anemia Treatment 2
- Co-authors
- Mary Ann Mascelli (7 shared papers)Eiko Toichi (3 shared papers)Daniel E. Everitt (3 shared papers)Charles E. Pendley (3 shared papers)Kevin D. Cooper (3 shared papers)Alice Bendix Gottlieb (3 shared papers)Thomas S. McCormick (3 shared papers)Catharine Lisa Kauffman (2 shared papers)
- Journals
- The Journal of Clinical Pharmacology (3 papers)British Journal of Clinical Pharmacology (2 papers)Clinical Therapeutics (2 papers)American Heart Journal (2 papers)The Journal of Immunology (1 paper)
- Partner nations
- United StatesNetherlandsJapan
In The Last Decade
Bart Frederick
20 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 72
- Immunology 595
- Dermatology 177
- Hematology 165
- Rheumatology 179
- Internal Medicine 25
Countries citing papers authored by Bart Frederick
This map shows the geographic impact of Bart Frederick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bart Frederick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bart Frederick more than expected).
Fields of papers citing papers by Bart Frederick
This network shows the impact of papers produced by Bart Frederick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bart Frederick. The network helps show where Bart Frederick may publish in the future.
Co-authors
The 25 scholars most cited alongside Bart Frederick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 227 | |
| 2 | 2006 | 180 | |
| 3 | 2001 | 177 | |
| 4 | 2007 | 92 | |
| 5 | 2009 | 87 | |
| 6 | 2011 | 87 | |
| 7 | 2011 | 76 | |
| 8 | 2013 | 37 | |
| 9 | 2020 | 36 | |
| 10 | 2008 | 35 | |
| 11 | 1988 | 20 | |
| 12 | 2002 | 19 | |
| 13 | 2013 | 19 | |
| 14 | 2019 | 13 | |
| 15 | 2014 | 11 | |
| 16 | 2000 | 11 | |
| 17 | 2006 | 7 | |
| 18 | 2005 | 3 | |
| 19 | 2013 | 3 | |
| 20 | 2002 | 2 |
About Bart Frederick
Bart Frederick is a scholar working on Immunology, Hematology, Radiology, Nuclear Medicine and Imaging, Rheumatology and Dermatology, having authored 20 papers that have together received 1.1k indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (4 papers), Biosimilars and Bioanalytical Methods (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Rheumatoid Arthritis Research and Therapies (3 papers), Dermatology and Skin Diseases (2 papers), Erythropoietin and Anemia Treatment (2 papers), Glycosylation and Glycoproteins Research (1 paper) and Complement system in diseases (1 paper). The work is most often cited by research in Immunology (595 citations), Dermatology (177 citations), Hematology (165 citations), Rheumatology (179 citations) and Internal Medicine (25 citations). Bart Frederick has collaborated with scholars based in United States, Netherlands and Japan. Frequent co-authors include Mary Ann Mascelli, Eiko Toichi, Daniel E. Everitt, Charles E. Pendley, Kevin D. Cooper, Alice Bendix Gottlieb, Thomas S. McCormick, Catharine Lisa Kauffman, Hugh M. Davis and Zhenhua Xu. Their work appears in journals such as The Journal of Clinical Pharmacology, British Journal of Clinical Pharmacology, Clinical Therapeutics, American Heart Journal and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.